Your browser doesn't support javascript.
loading
PARP Inhibitors for Prostate Cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) Blues.
Beije, Nick; Abida, Wassim; Antonarakis, Emmanuel S; Castro, Elena; de Wit, Ronald; Fizazi, Karim; Gillessen, Silke; Hussain, Maha; Mateo, Joaquin; Morris, Michael J; Olmos, David; Sartor, Oliver; Sharp, Adam; Sweeney, Christopher J; de Bono, Johann S.
Affiliation
  • Beije N; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Abida W; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Antonarakis ES; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain.
  • de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Fizazi K; Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France.
  • Gillessen S; Istituto Oncologico della Svizzera Italiana, Ente Ospedaliero Cantonale Bellinzona, Bellinzona, Switzerland.
  • Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
  • Mateo J; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Morris MJ; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Olmos D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain.
  • Sartor O; Tulane Cancer Center, Tulane University Medical School, New Orleans, LA, USA.
  • Sharp A; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.
  • de Bono JS; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: johann.de-bono@icr.ac.uk.
Eur Urol ; 84(3): 253-256, 2023 09.
Article in En | MEDLINE | ID: mdl-37087376
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Poly(ADP-ribose) Polymerase Inhibitors Limits: Humans / Male Language: En Journal: Eur Urol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Poly(ADP-ribose) Polymerase Inhibitors Limits: Humans / Male Language: En Journal: Eur Urol Year: 2023 Document type: Article Affiliation country: Country of publication: